Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday
Analysts adjusted price targets for several companies. Inspire Medical (INSP) raised to $97, Securitize (SECZ) to $13, Cleveland-Cliffs (CLF) to $17.48, Credo (CRDO) cut to $245, Colgate-Palmolive (CL) to $95, TTM (TTMI) to $175, Waters (WAT) to $515, Microsoft (MSFT) to $608, Ciena (CIEN) to $550, T-Mobile (TMUS) to $260.
How this was made
The 30-second read
Why it matters
Analyst revisions provide modest directional cues but lack new fundamental information, limiting trading impact.
Market read
Price‑target adjustments may cause short‑term trading interest but are not primary catalysts.
What to watch
Potential macro‑economic headwinds and upcoming Fed decisions could dominate market direction.
Background
The article aggregates recent analyst price‑target updates for a set of U.S. stocks after recent earnings cycles.
Ticker impact
Freedom Capital Markets raised INSP price target to $97 from $71.
Potential modest upside as target rises.
Target increase signals improved outlook, but no new fundamentals disclosed.
Rosenblatt increased SECZ price target to $13 from $11.
Likely modest price gain.
Target raise reflects optimism but lacks fresh catalyst.
GLJ Research raised CLF price target to $17.48 from $15.6.
Small upside expected.
Target lift suggests better outlook, no new data.
Mizuho cut CRDO price target to $245 from $290.
Potential downside.
Lower target reflects weaker expectations.
Piper Sandler cut CL price target to $95 from $98.
Minor downside risk.
Target cut signals modest concerns.
Needham slashed TTMI price target to $175 from $220.
Potential notable decline.
Large reduction reflects weaker outlook.
Goldman Sachs raised WAT price target to $515 from $465.
Modest upside expected.
Analyst confidence rises, no new fundamentals disclosed.
Cantor Fitzgerald raised MSFT price target to $608 from $522.
Potential short-term rally.
Target lift reflects optimism but lacks fresh catalyst.
Market effects
Analyst target revisions across healthcare, industrials, and tech may slightly shift sector sentiment.
U.S. equities may see modest rebalancing as investors adjust positions based on new targets.
Limited; primarily affects U.S. listed companies.
Counterpoint
Target changes may be premature without fresh earnings data; price moves could be muted.
Key entities
- AnalystCantor Fitzgerald
Raised Microsoft price target.
- AnalystGoldman Sachs
Raised Waters Corp target.
